Glycopyrrolate Injection · DIN 02382857 · 0.2 mg/mL · injection solution
Limited Use, Reason for Use code 481 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 481 required
Write on scriptReason for Use code 481 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 481
Reason for Use code 481
For the management of patients receiving palliative care*.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
*The patient must have a progressive life-limiting illness and require this medication for palliative purposes.
1 brand, same coverage
Glycopyrrolate Injection · DIN 02382857
Manufacturer: Omega Laboratories Ltd.; listing date 2015-03-31
Health Canada: Marketed since 2012-06-29 · brand GLYCOPYRROLATE INJECTION · ATC A03AB02 GLYCOPYRRONIUM · form Liquid · route Intramuscular, Intravenous · ingredients GLYCOPYRROLATE 0.2 MG/ML · company Omega laboratories limited · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product recordGlycopyrrolate Injection: Formulary list price $2.78 per unit (the source does not state the unit; exact figure $2.7825). What the ministry pays, not the patient.
Ministry pays: $2.7825 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02382857)
Source record
DIN 02382857: Glycopyrrolate Injection
Raw flags: sec12=Y, sec3=Y
Item: 120808010; group id 214; item number 0388; lccId 00288; manufacturer id OMG
Source form: Inj Sol; strength: 0.2mg/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.7825; ministry $2.7825
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02382857
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86866
Interchangeable products
Glycopyrrolate Injection USP · DIN 02473879 · $2.7825
Robinul · DIN 02043610 · not recorded
Sandoz Glycopyrrolate · DIN 02039508 · $2.7825
Shortage status: shortage reported ended September 3, 2026 (report last updated September 3, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02382857
Shortage record checked October 6, 2026